Scientists reveal the mRNA of human cytoplasmic arginyl-tRNA synthetase recruits prokaryotic ribosome independently
Source:
Time: 2015-09-20
There are two isoforms of cytoplasmic arginyl-tRNA synthetase (hcArgRS) in human cells. The long form is a component of the multiple aminoacyl-tRNA synthetase complex (MSC) and another is a N-terminal truncated form (NhcArgRS), free in the human cytoplasm. It has been shown that the two forms of ArgRS arise from alternative translational initiation in a single mRNA encoding hcArgRS. The short form is produced from the initiation at a downstream in-frame AUG start codon.
Dr. YANG Fang and colleagues led by Prof. WANG Enduo, at the Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, found that the alternative translational initiation of hcArgRS mRNA also takes place in E. coli transformants. Two isoforms of ArgRS were found when hcArgRS was over-expressed in E. coli. Those two isoforms are identical to the forms of hcArgRS in human cytoplasm. The short protein is also produced from the alternative translational initiation in the same mRNA. Further analysis revealed that the mRNA encoding N-terminal extension of hcArgRS can recruit E. coli ribosome independently. Two critical elements for recruiting the prokaryotic ribosome were identified, the “AGGA” core of Shine-Dalgarno sequence and the “A-rich” sequence located just proximal to the alternative in-frame initiation site. This study may provide the mechanism of alternative translational initiation of hcArgRS mRNA in human cells.
This study entitled “
The mRNA of human cytoplasmic arginyl-tRNA synthetase recruits prokaryotic ribosome independently” was published online in
Journal of Biological Chemistry on June 4, 2014. The work was supported by grants from the National Natural Science Foundation of China and the Natural Key Basic Research Foundation of China.
The mRNA encoding N-terminal 72-peptide (N72) of hcArgRS recruits E. coli ribosomes. (Image provided by Prof. WANG Enduo’s group)